Introduction: An integer-based risk score predicting inhospital mortality following pancreatectomy was published in 2010 by Hill et al using the Nationwide Inpatient Sample database. We attempt to externally validate this study using National Cancer Database (NCDB). Methods: Using NCDB a cohort of 14,971 pancreatic adenocarcinoma patients who underwent curative pancreatectomy during 2003-2011 was evaluated. In this cohort 80% of the patients were in training set and remaining belong to validation set. Clinicopathologic and demographic data were collected and, multivariable logistic regression to model the risk of in-hospital mortality was generated. Bootstrap methods were used to create integer based risk score. Results: Four independent variables were significantly predictive of in-hospital mortality; age, annual hospital volume, comorbidity index and type of resection. Integer values were assigned to each and were used for calculating the additive score. The estimated in-hospital mortality was stratified to low, medium and high-risk groups (1.46%, 3.31%, and 7.34%) with a five-fold difference between the low and high-risk groups. Our C-index for our training set and validation set was 0.65 and 0.66, respectively, suggesting that the model may not be a reliable one. Conclusion: Our study fails to validate the integer-based risk scoring system to predict in-hospital mortality after pancreatectomy as previously published. Introduction: The prognosis of pancreatic carcinoma (PC) remains poor and the AJCC 8th staging system for survival prediction in PC patients after curative resection is still limited. Methods: The data of 3,458 patients used in this study were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. The prognostic value of lymph node ratio (LNR) was analyzed in the primary cohort and prognostic nomogram based on LNR was established to create a novel staging system. Then, analyses were conducted to evaluate the application of the formulated nomogram staging system and AJCC 8th staging system. Results: Significant positive correlations were found between LNR and all factors except for surgical procedures. The results of univariate and multivariate analysis showed, LNR was identified as an independent prognostic indicator for OS in both primary and validation cohorts (all P< 0.001). A prognostic nomogram based on LNR was formulated to obtain superior discriminatory abilities. Compared with the AJCC 8th staging system, the formulated nomogram staying system showed higher HRs of stage II, III and IV disease (reference to stage I disease) by univariate analyses in the primary cohort and the distinction between stage I, II and III disease of the survival curves was more apparent. Conclusion: LNR can be considered as a useful independent prognostic indicator for PC patients following curative resection regardless of the surgical procedures. Compared with the AJCC 8th staging system, the formulated nomogram showed superior predictive accuracy for OS and its novel staging system revealed better risk stratification. Introduction: The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor owing to its difficulty in diagnosis and therapy. Immunotherapy has revealed its robust performance in several malignancies. Methods: The tissue microarray was stained and analyzed associated with clinicopathological characteristics. The preclinical murine models administrated with various immunotherapies were analyzed by growth inhibitor, flow cytometry, ELISA and immunohistochemistry. Results: The infiltrating FoxP3 + regulatory T cells (Tregs) and PD-1 expression in tumor tissues were associated with survival, while CD8+ infiltrating T cells (TILs) was lack of evidence. Then, CD8, FoxP3 and PD-1 expression were merged together to create a new estimated valuedintegrated immune ratio (IIR) comprehensively considering their drawbacks, which showed excellent distinction in risk stratification of survival. IIR was verified as an independent prognostic factor according to multivariate analysis, so did T and N classification. In the preclinical murine model, CD25 and TGF-b combinational blockade revealed higher tumor growth inhibitor value. Under overall consideration, the combinational therapy significantly depleted periphery and intratumoral FoxP3 + Tregs and enhanced intratumoral CD8 + T cells compared to control or anti-TGF-b monotherapy (all P< 0.05). The intratumoral IL-10, TGF-b was notably lower associated with higher IFN-g excretion with the combinational immunotherapy. Such combinational immunotherapy was further verified to synergize with anti-PD-1 monotherapy to promote the tumor growth inhibitor and cure rate. Conclusion: The combination of CD25, TGF-b and PD-1 blockade has a potentially effective role in inhibiting tumor formation and progression, and provides a strong rational strategy in clinical trials on the basis of IIR.
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